and was one to two orders of magnitude higher than in plasma or liver. Infusion of pregnenolone sulfate in ADWCX rats elicited a fourfold increase in 5~ DHP and progesterone content and a seven-to eightfold increase in the content of allopregnanolone in brain but not in liver or plasma. Furthermore, the content of allopregnanolone in brain increased to the same extent in both sham-operated and ADX/CX rats following pregnenolone sulfate infusion. The 5cY-reductase inhibitor, (17P)17 [[bis(lmethylethyl) 
androstane-3,5-diene-3-carboxylic acid (SKF 10511 l), reduced the brain content of allopregnanolone and blocked the increased formation of allopregnanolone in brain following pregnenolone sulfate infusion. The results clearly demonstrate that the synthesis of allopregnanolone from 5~DHP and progesterone occurs in the brain and that a significant amount of allopregnanolone is synthesized locally in brain from its precursors. These experiments suggest that the brain, like adrenals and gonads, is a steroidogenic organ which produces allopregnanolone as one of its own most important physiologically relevant steroids.
[Key words: gas chromatography, mass fragmentography, allopregnanolone, progesterone, pregnenolone, 5~ dihydroprogesterone, adrenalectomy, castration, neurosteroids]
The CNS has the capacity to synthesize steroids (neurosteroids) de nova from cholesterol (Baulieu and Robel, 1990; Guarneri et al., 1992; Romeo et al., 1993) . Among the neurosteroids, ~CX-pregnan-3o-ol-20-one (allopregnanolone), which is synthesized in brain from by the action of 3o-hydroxysteroid oxidoreductase (~cx-HSOR) (Karavolas and Hodges, 1991) is pharmacologically the most potent and specific modulator of neuronal activity. Allopregnanolone, in nanomolar concentrations, either increases the strength of ionotropic GABAergic synaptic transmission (Majewska et al., 1988; Mienville and Vicini, 1989; Paul and Purdy, 1992; Puia et al., 1992 Puia et al., , 1993 or is oxidized to 5o-DHP which can then alter gene expression via its interaction with progesterone receptors (Rupprecht et al., 1993) .
These discoveries have opened an exciting new field of research on the regulation of neurosteroid synthesis in the central nervous system and have emphasized the urgent need for sensitive, selective and structure specific assays to measure the tissue concentrations of various steroids including the neurosteroids. Consequently, during the past few years numerous highly sensitive assays utilizing radioimmunoassay (RTA) have been developed (Corpechot et al., 1983; Jo et al., 1989; Purdy et al., 1990; Corpechot et al., 1993) . Because of the large number of endogenous steroids that are structurally similar and because of the insufficient selectivity and specificity of the antibodies that are available for use in these assays, the RIA methods, even when combined with high performance liquid chromatography (HPLC), do not offer a reliable criterion to measure neurosteroid content with sufficient specificity for structural identification (Siekmann, 1979; Corpechot et al., 1993) . Consequently, literature values for the content of neurosteroids in the brain vary widely (Rohle and Breuer, 1978; Wood et al., 1985; Thienpont et al., 1991) and extensive sample purification steps with inherent product loss are necessary to avoid quantification errors due to cross reactivity or to the presence in tissue extracts of contaminating substances which interfere with the RIA (Purdy et al., 1990 (Purdy et al., , 1991 Morfin et al., 1992; Corpechot et al., 1993) . Korneyev et al. (1993) found it necessary to pass samples extracted from brain tissue through three different HPLC columns in order to eliminated endogenous substances which interfered with the RIA tissue analysis of pregnenolone.
There has been recent interest in the rapid and long lasting neuromodulatory actions of allopregnanolone (Corpechot et al., 1993) . The entire pathway of allopregnanolone biosynthesis in brain including pregnenolone conversion to progesterone via the action of 3P-hydroxysteroid dehydrogenase and progesterone conversion to Sex-DHP via the action of So-reductase (Baulieu and Robel, 1990; Purdy et al., 1990; Karavolas and Hodges, 1991; Corpechot et al., 1993) has become an interesting subject of studies to establish the physiological relevance of allopregnanolone. Moreover, there is a need to identify drugs that can increase brain availability of this neurosteroid. These considerations prompted us to develop methodologies which are able to measure levels of neurosteroids, and their precursors unambiguously. This goal was achieved by coupling HPLC with gas chromatography-mass fragmentography (CC-MF). The steroids may be identified, first, by their HPLC retention times, second by their CC retention times and, third, by their unique fragmentation spectra following derivatization with heptafluorobutyric anhydride (HFBAA) or methoxyamine HCl. For structural identification the pattern of current intensities generated by specific ions can be compared with the pattern generated by the specific ions of an appropriate internal standard. This hierarchical approach per se yields a high degree of specificity, which is enhanced in the Selected Ion Monitoring (SIM) mode that allows for the focussing on one or a few specific ions bearing structural information. This procedure optimizes the specificity of the assay and also reduces the chemical noise of the analysis which increases its sensitivity.
Using this method we report the regional brain distribution and plasma and liver content of allopregnanolone and its parent compounds following intravenous administration of pregnenolone sulfate in adrenalectomized (ADX) and castrated (CX) rats. These studies aim to respond to the fundamental question: can allopregnanolone be synthesized in brain in quantities sufficient to modulate neuronal activity?
Materials and Methods

Animals.
Male, sham operated and ADX/CX Sprague-Dawley rats (220-240 gm body weight) were supplied by Zivic-Miller (Zelionople, PA) and housed in groups of four to five with 12/12 hr dark/light cycle from 7:00 A.M. to 7:00 PM. and were provided with food and physiologic saline ad libitum. Fifteen to 21 d after adrenalectomy and castration rats were restrained in animal holders and infused with either vehicle (dimethyl sulfoxide (DMSO), 4.5%, a solution of 15% B-hydroxycyclodextrin, 22.4%; saline, 73.1%) or pregnenolone sulfate dissolved in the vehicle (48 p,mol/kg; 0.34 ml/min; 5 min) and sacrificed by decapitation 20 min after stopping the infusion. Blood was collected in heparinized tubes and plasma samples were obtained by centrifugation at 2000 X g for 15 min at 4°C. The entire brain was quickly removed and, when appropriate, brain parts were dissected and tissues were frozen on dry ice and stored at -20°C. All animal procedures were in strict accordance with the NIH guide for The Care and Use of Laboratory Animals and were approved by the Animal Care Committee. androstane-3,5-diene-3-carboxylic acid) was a gift from Smith Kline Beecham Pharmaceuticals, King of Prussia, PA. All solvents used were HPLC grade. Tritiated-So-DHP was enzymatitally synthesized from 'H-allopregnanolone in C6-2B cells from which the 'H-So-DHP was extracted and purified using HPLC. Pregnenolone sulfate (Sigma, St. Louis, MO) was chromatographicahy pure and did not contain detectable amounts of allopregnanolone (CO.6 pmollml), progesterone (CO.3 pmollml), or pregnenolone (CO.3 pmol/ml) when the solution of pregnenolone sulfate to be infused (12 ~mol/ml) into the animals was analyzed by HPLC/GC-ME Preparation of samples. In preparation to measure the steroids, rat plasma, liver, and brains were homogenized in 5 volumes of 0.4N formic acid using a Brinkman polytron; approximately 9000 CPM (-0.05 pmol each) of 'H-pregnenolone, 'H-progesterone, 'H-5o-DHP and ?Hallopregnanolone were added to the homogenate to monitor recovery and to identify which fractions contained the steroids of interest. The homogenates were extracted with 20 ml of ethyl acetate and twice with I5 ml of ethyl acetate. The supernatants were collected, pooled, and lyophilized in preparation for HPLC.
HPLC separation of allopregnanolone, Scu-DHP, progesterone, and pregnenolone.
Tissue extracts (up to 2 gm of brain, 3 gm of liver or 3 ml of plasma) were resuspended in hexane (1 ml). They were filtered through 13 mm diameter Gelman PTFE filters (0.2 p,rn pore size) and were injected onto the HPLC. HPLC separation of the steroids was carried out using a 10 pm Lichrosorb 100 Dial, 4 X 250 mm column (EM Science, Gibbston, NJ). The column was equilibrated with hexane at a flow rate of 1 mllmin and was developed with a tetrahydrofuran (THF) gradient using a linear increase to 8.0% in 15 min, a second linear increase to 13% in 30 min, and a final linear increase to 100% in 15 min. After running the gradient the column was washed with methanol at a flow rate of 1 mllmin for 30 min in order to remove contaminants that elute from the column. Fractions eluting from the HPLC were collected at 1 min intervals and the radioactivity was counted to determine the retention time of the individual steroids. TritiatedSo-DHP 'H-progesterone, 'H-allopregnanolone, and xH-pregnenolone were eluted with retention times of 19-21 mitt, 28-30 min, 37-39 mitt, and 4244 min, respectively (Fig. 1) . Consistently, the recovery was between 87% and 93%.
CC-MF separation and analysis.
To the HPLC fractions containing progesterone, 15 pmol of allopregnanolone was added as an internal standard; to the fractions containing allopregnanolone 7.5 pmol of progesterone were added as an internal standard; and to the fractions containing pregnenolone, 15 pmol of allopregnanolone were added as an internal standard. These fractions were evaporated to dryness under a stream of nitrogen, and the residues were dissolved in 100 pl of acetone. Twenty-five microliters of HFBAA were added as a derivatizing reagent and the samples were allowed to stand at room temperature for I hr (Bjorkhem et al., 1975) . The reaction mixture was evaporated to dryness under a stream of nitrogen and the HFBAA-derivatives were dissolved in IO-20 ~1 hexane. To the HPLC containing 5o-DHP 15 pmol of progesterone was added as an internal standard, 50 ~1 of methoxyamine HCI (2%) in pyridine and the samples was reacted for 1 hr at 65°C. The derivatizing reagents were evaporated to dryness under a stream of nitrogen. The residue was taken up in I ml chloroform:hexane (1:l) and passed through a short column (-3 cm) of Sephadex LH-20. The of Neuroscience, June 1995, 15(6) 4643 column was washed with 1 ml chloroform:hexane (I : I). The void volume (2 ml) containing the methoxime (MO)-derivatives was evaporated to dryness and the MO-derivatives were dissolved in lo-20 ~1 hexane. HFBAA-and MO-derivatives of the steroids were analyzed by GC-MF using an HP 5971 Mass Selective detector coupled to an HP 589OA gas chromatograph. The gas chromatograph was equipped with a Hewlett Packard capillary column (HP-5 MS.: length. 30 m: i.d.. 0.25 mm: film thickness,-0.25-p) Helium was used as the'carrier gas. The tern: peratures of the transfer line and the ion source were 280°C and 18O"C, respectively, and the temperature of the injection port was 250°C. Two to three microliters of the hexane containing the HFBAA-or MO-derivatives were injected on the column equilibrated at low temperature (50°C) at a pressure of 50 psi in order to concentrate the sample and reduce the peak width. In order to concentrate the sample further, the pressure was increased to 70 psi for 1 min. After 1 min the gas pressure was programmed to maintain a 10 ml/min flow rate while the temperature was programmed to increase at a rate of 30"C/min until a temperature of 230°C was reached. A column temperature of 230°C was maintained during the remainder of the injection cycle.
Statistical analysis. All results are mean + SEM. Data were subjected to Student's t test or an analysis of variance followed by NeumanKeuls test.
Results
Identijcation and quantitation of allopregnanolone, Scu-DHP, progesterone, and pregnenolone in brain Mass spectrometric ident$cation of neurosteroids. Samples containing tissue extracts (after HPLC purification and separation) or known quantities of allopregnanolone, .5o-DHP, progesterone, and pregnenolone were reacted with HFBAA or methoxyamine HCl in pyridine. HFBAA formed 3-enol-hepta-fluorobutyric ester derivatives of allopregnanolone, progesterone, and pregnenolone ( Fig. 2) but did not react with 5o-DHP Methoxyamine HCl formed 3, 20-methoxime derivatives of progesterone and So-DHP (Fig. 3) . Following derivatization and ionization of the neurosteroids in the mass spectrometer, positive ions with masses between m/z 100 and m/z 550 were recorded. The mass spectra of the neurosteroids were virtually identical in both standards and brain extracts (see Fig. 2 ). HFBAA-progesterone had only one major ion, the molecular ion m/z 510. The relative abundance of the other ion fragments was almost negligible. The molecular ion (m/z 514) was not present in the spectrum for HFBAA-pregnenolone, but the base peak, m/z 298, was of high intensity. In contrast, the mass spectrum of HFBAA-allopregnanolone was complex in that there were a number of intense ion fragments which reduced the sensitivity. The molecular ion was observed at m/z 5 14 and the base peak was observed at m/ z 496 (Fig. 2) . The mass spectrum of MO-So-DHP showed a molecular ion at m/z 374 and the base peak at m/z 343 (Table  1) .
Steroids with ketone groups at the position 3 were expected to form two geometric isomers of the syn and anti type upon formation of the oxime derivatives (Koshy et al., 1975) . When the keto steroid progesterone was reacted with methoxyamine HCl two peaks were observed (Fig. 3) which may correspond to the syn and anti isomers. Two peaks were also observed for MO-Sex-DHP which presumably correspond to the syn and anti isomers, but only one peak was observed for its stereoisomer, SB-DHP (Fig. 3) . By varying the temperature and pressure in the gas chromatographic column, a base line separation for the two peaks of MO-So-DHP and of MO-progesterone could be obtained; however, it was not possible to resolve MO-5B-DHP into two peaks using the 30 m HP-5 MS. capillary column. The fragmentation patterns of MO-SB-DHP and for peaks A and B of MO-So-DHP were identical. The four major ion fragments were &z 275, 288, 343 (base peak) and 374 (molecular ion) (Table 1 ) and had the same relative abundance. Five-B-DHP was not observed in rat brain extracts. Calculations indicate that if this steroid were present in brain its quantity would be less than 1.6 pmol.
The neurosteroid identification was optimized further by using the mass spectrometer in the SIM mode. In this mode the derivatized steroids were identified by their CC retention time (GC-RT) and the ratio between two specific mass/charge (m/z) fragments (Table 2) . A ratio differing by more than 20% indicates the possible interference by a contaminating ion fragment. Once the analyzing conditions were established, in a manner that excluded interference from unwanted ion fragments, it was possible to increase the detection sensitivity for routine analyses by focusing on only one specific m/z value for each derivatized steroid: pregnenolone, 298 m/z; progesterone, 5 10 m/z; Sol-DHP, 343 m/z; and allopregnanolone, 496 m/z).
Quantitation of neurosteroids. Following separation of the steroids by HPLC, fractions containing the individual steroids, as identified by trace amounts of radioactivity added to the extracts and the internal standards (see Materials and Methods), were combined. The samples were evaporated to dryness, derivatized and analyzed by GC-ME For each tissue sample the area under the steroid peak containing an unknown quantity of steroid was divided by the area under the internal standard peak. With this ratio the content of the steroid was read from the external standard curve. The external standard curve was prepared by adding the internal standards as indicated above to varying amounts of the individual steroids. The area under the peak of a known quantity of added steroid was divided by the area under the peak of internal standard. This ratio was plotted against the quantity of added steroid. A standard curve of allopregnanolone is shown in Figure 4 prepared from data of several experiments.
Precision of the assay procedures was determined in tissue samples injected in quadruplicate.
In this way the variability between different samples of neurosteroids could be accounted for in multiple assays of the same sample. The GC-MF values obtained in the absence of added steroids were subtracted from the values obtained in the presence of added steroids and the data were analyzed by a one-way ANOVA.
The results of the analysis of variance are shown in Table 3 . As expected the intraassay variation is lower for all four steroids than the interassay variation as indicated by the smaller values for the mean squares. Moreover, the ratio of the variances (F value) indicates that the variation between means of the different samples did not reach the level o'f significance at p < 0.5 (Table 3) .
Accuracy was expressed as the calculated concentration divided by the actual concentration expressed as a percentage. The calculated concentration approximated the actual concentration with a difference of less than 2% for every steroid tested. The sensitivity was determined by the limit of detection wherein the mass-spectrometer recognized a peak at the appropriate retention time and the peak yielded a signal to noise ratio of at least three (Table 3 ). The limits of detection were lowest for progesterone and pregnenolone (about 0.32 pmol) which had simple mass fragmentation patterns and greatest for 5o-DHP (1.6 pmol) which displayed dual peaks. Allopregnanolone had a detection limit of approximately 0.63 pmol (see also Fig. 4 ).
Allopregnanolone, SCY-DHP, and progesterone in brain, plasma, and liver of normal and ADWCX rats Figure 2 . Mass spectra of the HFBAA-derivatives of allopregnanolone, pregnenolone, and progesterone from brain and standards. fold higher than plasma and more than 50-fold higher than liver. In fact, plasma and liver had barely detectable levels of allopregnanolone (Fig. 5) . The brain content of Sa-DHP, the precursor of allopregnanolone, was comparable to that of allopregnanolone and was five-to sixfold higher in brain than in plasma. 5~DHP was virtually nondetectable in liver (Fig. 5 ). Brain and plasma content of 5a-DHP and progesterone (the precursor of SCY-DHP) decreased markedly (70 and SO%, respectively) when adrenals and gonads were removed (Fig. 5) . In contrast, allopregnanolone content decreased only partially (30%) in brain and remained low but virtually unchanged in plasma and liver in spite of the fact that adrenalectomy and castration were performed at least 15 d before the measurement (Fig. 5) .
Allopregnanolone, pregnenolone, progesterone, and SCY-DHP in brains of ADXKX rats infused with pregnenolone sulfate
To further demonstrate that in ADXKX rats the persistent, high content of brain allopregnanolone is derived from a brain biosynthetic pathway, ADX/CX rats were infused with pregnenolone sulfate. Pregnenolone sulfate was used because it is a more soluble precursor than pregnenolone for intravenous studies. Twenty min following infusion of pregnenolone sulfate (48 pmol/kg; 0.34 ml/min; 5 min) in ADXKX rats the content of (Table 4 ). In the same animals the brain content of allopregnanolone increased by seven-to eightfold, whereas the brain content of allopregnanolone in sham-operated rats increased by four-to fivefold (Fig. 6) . Thus, following pregnenolone sulfate infusion the brain content of allopregnanolone was considerably elevated and was similar in brains of sham-operated and ADX/CX rats (Fig. 6) . Infusion of pregnenolone sulfate also caused a significant increase in brain content of So-DHP and progesterone (Table 4 ). The level of progesterone (25 + 5.1 pmol/gm) and 5~DHP (3.8 ? 1.1 pmol/gm) following infusion of pregnenolone sulfate in ADX/CX rats reached concentrations similar to those found in brain of sham-operated rats (progesterone, 37 + 7.6 pmol/gm; So-DHP, 3.8 2 0.8 pmol/ gm) (compare Table 4 with Fig. 5 ). In contrast, in ADX/CX rats infused with pregnenolone sulfate, the plasma content of allopregnanolone ( Fig. 6 ) and So-DHP (0.37 ? 0.22, IZ = 5, ADX/ CX rats; 0.22 t 0.046, II = 5, ADX/CX rats infused with pregnenolone sulfate) failed to increase, although the plasma content of progesterone increased from 0.57 ? 0.21 (n = 5) in ADX/ CX rats to 3.0 2 1.1 pmol/ml (n = 5) in ADX/CX rats infused with pregnenolone sulfate. In liver, the content of allopregnanolone, So-DHP, and progesterone in ADX/CX rats treated with pregnenolone sulfate did not increase and remained virtually undetectable. These data strongly suggest that following pregnenolone sulfate infusion the large increase of allopregnanolone and its immediate precursor, Sa-DHP in brain are not due to their biosynthesis in peripheral tissues.
Allopregnanolone content in various brain regions
A strong argument in support of local brain biosynthetic pathways for allopregnanolone would be to demonstrate that allopregnanolone is distributed nonuniformly in brain. Figure 7 shows that in ADX/CX rats allopregnanolone was not uniformly distributed in olfactory bulb, cortex, hippocampus, striatum and cerebellum. The olfactory bulb had the highest concentration of allopregnanolone (8.3 pmol/gm brain). The concentrations of allopregnanolone found in cortex, hippocampus, cerebellum and (Fig. 7) . To rule out the possibility that the uneven distribution of brain allopregnanolone may be the result of a nonuniform brain uptake of pregnenolone, progesterone, Sa-DHP or allopregnanolone, 'H-pregnenolone, 'H-progesterone, 3H-5a-DHP, and 'H-allopregnanolone (2 &i/20 pmol/ 1.8 ml saline) were infused intravenously in rats via the tail vein. The radioactivity associated with authentic pregnenolone, progesterone, So-DHP, or allopregnanolone was determined in each of the brain areas after extraction with ethyl acetate and HPLC separation. All of the steroids tested produced a uniform distribution throughout the various areas of the brain.
Effect of the Swreductase inhibitor SKF-1051 I I on allopregnanolone bruin content
To determine whether So-reductase, the enzyme that catalyses the conversion of progesterone to SWDHP, is responsible for allopregnanolone biosynthesis, the allopregnanolone content in selected brain areas of ADX/CX rats was determined 30 min following the injection of the type 1 and type 2 5a-reductase inhibitor, SKF-105111 (Levy et al., 1989 , 1990 Mark Levy, personal communication) , with and without pregnenolone sulfate infusion. In previous experiments in rats we demonstrated that SKF-105 1 11, in doses of 1 1.7. pmol/kg was capable of preventing the anti-amnesic effect of pregnenolone sulfate in a behavioral paradigm after dizocilpine treatment (Romeo et al., 1994) . Following administration of this dose of SKF-105111, the content of allopregnanolone decreased significantly in olfactory bulb, cortex, hippocampus, and striatum. Moreover, the increased allopregnanolone content elicited by pregnenolone sulfate was virtually abolished in the several brain areas studied (Fig. 7) . and Robel, 1990; Majewska, 1990; Morrow et al., 1990; ParkChung et al., 1994) and gene expression via conversion to 501-DHP (Rupprecht et al., 1993) , numerous antibodies have been developed for the determination of the levels of pregnenolone, progesterone, So-DHP and allopregnanolone using RIA (Corpechot et al., 1983; Jo et al., 1989; Purdy et al., 1990; Corpechot et al., 1993) . However, the results of several studies indicate that neurosteroid concentrations measured by RIA vary considerably from one laboratory to the other (Rohle and Breuer, 1978; Purdy et al., 1990; Morfin et al., 1992; Corpechot et al., 1993) . This is probably due to the low specificity of various antibodies which were, and are currently, in use for radioimmunoassays of steroids. While using RIA as a routine assay, investigators have adopted the comparison between RIA determinations and semiquantitative GC-MF identification of the steroids in selected samples to establish whether a steroid concentration is accurate or not (Akwa et al., 1993; Corpechot et al., 1993; Korneyev et al., 1993) . However, as yet, no GC-MF method has been developed for routine simultaneous quantitation of pregnenolone, progesterone, So-DHP, and allopregnanolone in brain samples. The present work reports the development and use of highly specific, accurate and sensitive GC-MF methodology utilizing electron ionization that can be used to quantitate these neurosteroids in discrete brain areas of the rat. Neurosteroids, separated ALLOPREGNANOLONE (pmolesl on an HPLC column and identified by their retention times, were derivatized and injected onto a GC-capillary column where they were further separated from coeluting contaminants and identified by their GC-retention times. The HFBAA-derivatives of pregnenolone, progesterone, and allopregnanolone and the MO-derivative of 5o~-DHP were less polar, more volatile and had higher molecular weights than the underivatized steroids. The moiety derived from HFBAA added 196 mass units to the respective molecule whereas the moiety derived from methoxyamine HCl added 58 mass units. This increase in molecular weight allowed the ion fragments to be monitored in a region of the mass spectrum that had less interference from the biological material or from the bleed of the stationary phase of the column.
So-DHP was derivatized with methoxyamine HCl because So-DHP does not react with HFBAA.
Steroids, with a keto group as position 3, such as 5c~-DHP and progesterone, form geometric isomers of the syn and anti type (Koshy et al., 1975) when derivatized with methoxyamine HCl were expressed as dual peaks. Although, on one hand, the formation of two peaks instead of one caused a loss of detection sensitivity (see Table  3 ), on the other hand, the dual peaks for MO-So-DHP and the internal standard, MO-progesterone, actually aided in the identification of the steroids. The characteristics of the ion pattern emerging from the mass spectrometer and the constant ratio between peaks A and B increased the confidence that there were no interfering ions.
An estimate of the precision with which the quantitative measurements of the neurosteroids could be reproduced by our method was obtained from an ANOVA.
Both within-and betweenassay variations were determined and no significant differences were found between the ratio of the variances indicating an acceptable level of precision. For these methods internal standards were added at the beginning of the procedures. Because of the cost of custom synthesis of stable isotope-labeled analogs (Giovannini et al., 1991) of each of the steroids of interest, we used internal standards which were close homologs of the neurosteroids of interest. They differed by a double bond, a substituted hydroxyl or ketone group and had different gas chromatographic retention times and different m/z, values. Because of their similar chemical characteristics, they provided the steroid quantitation with an acceptable degree of precision (Table 3) .
Accuracy was determined from the ratio of the calculated concentration of steroid to the actual amount added. The error in the calculated concentrations of added neurosteroid was within l-2%. The limit of detection was lowest (CO.32 pmol) for pregnenolone and progesterone because of their more simple fragmentation spectra and highest (< 1.6 pmol) for So-DHP. The sensitivity achieved by this method allowed the accurate mea- and Purdy, 1992; Puia et al., 1994) . It is known that allopregnanolone is present and persists in brain of rats long after the adrenals are removed (Purdy et al., 1992) , but there is very limited quantitative data available to suggest that changes in brain GABA receptor function can be related to changes in allopregnanolone or Sex-DHP brain content.
Using the coupled HPLC/GC-MF technique we showed (Fig.  5 ) that brain contained nM concentrations of allopregnanolone and also demonstrated that these concentrations of allopregnanolone persisted in brain of rats from which adrenals and testis had been removed 15-21 d earlier.
To document that the allopregnanolone present in the brains of ADX/CX rats is synthesized in brain and is not transported there from blood after being synthesized in liver or some other peripheral organ, we measured the content of allopregnanolone in both plasma and liver. Since plasma levels of allopregnanolone in ADX/CX rats with or without pregnenolone sulfate infusion were virtually undetectable, we conclude that the persistent brain content of allopregnanolone is not derived from allopregnanolone synthesized in peripheral tissue and transported via blood to brain. This conclusion is confirmed by our experiments in liver. Liver contains high levels of 5a-reductase and 3a-HSOR and although the amount of progesterone in liver of ADX/CX rats is very small (Fig. 5) , this large organ could contribute significantly to blood-borne allopregnanolone especially in animals infused with pregnenolone sulfate. However, the content of allopregnanolone in liver of ADX/CX rats with or without pregnenolone sulfate infusion was particularly low and virtually below the level of detection.
Since allopregnanolone in brain may be synthesized from its precursors, Sa-DHP and progesterone, we adopted the strategy of infusing ADX/CX rats with pregnenolone sulfate to ensure an adequate amount of 5a-DHP and progesterone at the site of synthesis. When administered in large amounts pregnenolone sulfate is desulfated in peripheral tissue (i.e., liver) and significant amounts of pregnenolone can reach, and be evenly distributed throughout, the brain. The enzyme 3P-hydroxysteroid dehydrogenase which is the rate limiting step for the formation of progesterone from pregnenolone is present in brain (Robe1 et al., 1991) but is not found in most peripheral tissues with the exception of adrenal and testis which were removed in our animals. Thus, in ADX/CX rats infused with pregnenolone sulfate, the progesterone levels in liver were virtually undetectable. In the rats. Brain areas from four rats were pooled and samples were assayed in duplicate.
Data represent the mean t SEM of three to five duplicate assays for noninfused animals and 5-10 animals infused with pregnenolone sulfate. *, p < 0.05.
absence of progesterone, liver, although rich in 5ol-reductase and 3a+HSOR, was not able to synthesize 5cx-DHP and allopregnanolone. Therefore, we can presume that the large increase in allopregnanolone (Fig. 6) , progesterone, and Sex-DHP (Table 4 ) found in the brain of ADXICX rats infused with pregnenolone sulfate reflects a local synthesis of these steroids from pregnenolone.
Importantly, in ADX/CX rats we observed a nonuniform brain distribution of allopregnanolone with the highest content occurring in the olfactory bulb, striatum, and cortex. Following infusion of pregnenolone sulfate there was a uniform seven-to eightfold increase in brain allopregnanolone and the rank order of allopregnanolone content in various brain areas was identical to that of nonperfused rats. Those areas that have the highest content of allopregnanolone are the same areas in which the highest levels of .5ol-reductase activity and the highest conversion rate of progesterone to allopregnanolone have been demonstrated in brain slices (Karavolas and Hodges, 1991; Korneyev et al., 1993) . Moreover, the 5a-reductase inhibitor, SKF-105 111, reduced the brain content of allopregnanolone in the various brain areas and blocked the increase in allopregnanolone content induced by pregnenolone sulfate infusion. In conclusion, the work presented here utilizes a highly specific, accurate and sensitive HPLC/GC-MF technology to demonstrate a brain specific synthesis of allopregnanolone in quantities that may be relevant to a physiological modulatory role of neuronal activity for this neurosteroid.
These conclusions are based on the following observations. (I) Pharmacological relevant (nanomolar) concentrations of allopregnanolone were present in the brain of ADX/CX rats long
